nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Biochemical and biomechanical drivers of cancer cell metastasis, drug response and nanomedicine
|
Yoshii, Tatsuyuki |
|
2016 |
21 |
9 |
p. 1489-1494 6 p. |
artikel |
2 |
Bioengineered cell culture systems of central nervous system injury and disease
|
Teixeira, Fábio G. |
|
2016 |
21 |
9 |
p. 1456-1463 8 p. |
artikel |
3 |
Bioengineered vascular constructs as living models for in vitro cardiovascular research
|
Wolf, Frederic |
|
2016 |
21 |
9 |
p. 1446-1455 10 p. |
artikel |
4 |
Cell spheroids: the new frontiers in in vitro models for cancer drug validation
|
Chatzinikolaidou, Maria |
|
2016 |
21 |
9 |
p. 1553-1560 8 p. |
artikel |
5 |
Contents page 1
|
|
|
2016 |
21 |
9 |
p. i- 1 p. |
artikel |
6 |
Contents page 2
|
|
|
2016 |
21 |
9 |
p. ii- 1 p. |
artikel |
7 |
Current attempts to implement siRNA-based RNAi in leukemia models
|
Uludağ, Hasan |
|
2016 |
21 |
9 |
p. 1412-1420 9 p. |
artikel |
8 |
Dendritic-cell-derived osteoclasts: a new game changer in bone-resorption-associated diseases
|
Lapérine, Olivier |
|
2016 |
21 |
9 |
p. 1345-1354 10 p. |
artikel |
9 |
Engineered miniaturized models of musculoskeletal diseases
|
Bersini, Simone |
|
2016 |
21 |
9 |
p. 1429-1436 8 p. |
artikel |
10 |
Engineering in vitro complex pathophysiologies for drug discovery purposes
|
Gaspar, Diana |
|
2016 |
21 |
9 |
p. 1341-1344 4 p. |
artikel |
11 |
Harnessing gene and drug delivery for vascularizing engineered tissue platforms
|
Lam, Gabrielle C. |
|
2016 |
21 |
9 |
p. 1532-1539 8 p. |
artikel |
12 |
High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases
|
Rocha, Daniela N. |
|
2016 |
21 |
9 |
p. 1355-1366 12 p. |
artikel |
13 |
Immune-competent human skin disease models
|
Bergers, Lambert I.J.C. |
|
2016 |
21 |
9 |
p. 1479-1488 10 p. |
artikel |
14 |
In vitro and ex vivo models of multiple sclerosis
|
Madill, Martin |
|
2016 |
21 |
9 |
p. 1504-1511 8 p. |
artikel |
15 |
In vitro blood–brain barrier models for drug research: state-of-the-art and new perspectives on reconstituting these models on artificial basement membrane platforms
|
Banerjee, Jayati |
|
2016 |
21 |
9 |
p. 1367-1386 20 p. |
artikel |
16 |
In vitro models for assessing therapeutic angiogenesis
|
Sanz-Nogués, Clara |
|
2016 |
21 |
9 |
p. 1495-1503 9 p. |
artikel |
17 |
Microfluidic models for adoptive cell-mediated cancer immunotherapies
|
Adriani, Giulia |
|
2016 |
21 |
9 |
p. 1472-1478 7 p. |
artikel |
18 |
Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery
|
Smith, Alec S.T. |
|
2016 |
21 |
9 |
p. 1387-1398 12 p. |
artikel |
19 |
Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling
|
Skardal, Aleksander |
|
2016 |
21 |
9 |
p. 1399-1411 13 p. |
artikel |
20 |
Physiologically relevant human tissue models for infectious diseases
|
Mills, Melody |
|
2016 |
21 |
9 |
p. 1540-1552 13 p. |
artikel |
21 |
Recreating complex pathophysiologies in vitro with extracellular matrix surrogates for anticancer therapeutics screening
|
Shologu, Naledi |
|
2016 |
21 |
9 |
p. 1521-1531 11 p. |
artikel |
22 |
The next level of 3D tumour models: immunocompetence
|
Nyga, Agata |
|
2016 |
21 |
9 |
p. 1421-1428 8 p. |
artikel |
23 |
Three-dimensional ex vivo co-culture models of the leukaemic bone marrow niche for functional drug testing
|
Dhami, Sukhraj Pal S. |
|
2016 |
21 |
9 |
p. 1464-1471 8 p. |
artikel |
24 |
Towards 3D in vitro models for the study of cardiovascular tissues and disease
|
Ryan, Alan J. |
|
2016 |
21 |
9 |
p. 1437-1445 9 p. |
artikel |
25 |
Towards the development of an in vitro model of atherosclerotic peripheral vessels for evaluating drug-coated endovascular technologies
|
Cunnane, Eoghan M. |
|
2016 |
21 |
9 |
p. 1512-1520 9 p. |
artikel |